Your browser doesn't support javascript.
loading
Permissive epigenomes endow reprogramming competence to transcriptional regulators.
Kim, Kee-Pyo; Choi, Jinmi; Yoon, Juyong; Bruder, Jan M; Shin, Borami; Kim, Jonghun; Arauzo-Bravo, Marcos J; Han, Dong; Wu, Guangming; Han, Dong Wook; Kim, Johnny; Cramer, Patrick; Schöler, Hans R.
Afiliação
  • Kim KP; Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
  • Choi J; Department of Molecular Biology, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
  • Yoon J; Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
  • Bruder JM; Department of Early Discovery, Ksilink, Strasbourg, France.
  • Shin B; Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
  • Kim J; Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
  • Arauzo-Bravo MJ; Department of Stem Cell Biology, School of Medicine, Konkuk University, Seoul, Republic of Korea.
  • Han D; Department of Genetics, Yale School of Medicine, New Haven, CT, USA.
  • Wu G; Group of Computational Biology and Systems Biomedicine, Biodonostia Health Research Institute, San Sebastian, Spain.
  • Han DW; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
  • Kim J; Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
  • Cramer P; Department of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, Münster, Germany.
  • Schöler HR; Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China.
Nat Chem Biol ; 17(1): 47-56, 2021 01.
Article em En | MEDLINE | ID: mdl-32807969
ABSTRACT
Identifying molecular and cellular processes that regulate reprogramming competence of transcription factors broadens our understanding of reprogramming mechanisms. In the present study, by a chemical screen targeting major epigenetic pathways in human reprogramming, we discovered that inhibiting specific epigenetic roadblocks including disruptor of telomeric silencing 1-like (DOT1L)-mediated H3K79/K27 methylation, but also other epigenetic pathways, catalyzed by lysine-specific histone demethylase 1A, DNA methyltransferases and histone deacetylases, allows induced pluripotent stem cell generation with almost all OCT factors. We found that simultaneous inhibition of these pathways not only dramatically enhances reprogramming competence of most OCT factors, but in fact enables dismantling of species-dependent reprogramming competence of OCT6, NR5A1, NR5A2, TET1 and GATA3. Harnessing these induced permissive epigenetic states, we performed an additional screen with 98 candidate genes. Thereby, we identified 25 transcriptional regulators (OTX2, SIX3, and so on) that can functionally replace OCT4 in inducing pluripotency. Our findings provide a conceptual framework for understanding how transcription factors elicit reprogramming in dependency of the donor cell epigenome that differs across species.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histonas / Histona-Lisina N-Metiltransferase / Epigênese Genética / Reprogramação Celular / Células-Tronco Pluripotentes Induzidas / Células-Tronco Embrionárias Humanas Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histonas / Histona-Lisina N-Metiltransferase / Epigênese Genética / Reprogramação Celular / Células-Tronco Pluripotentes Induzidas / Células-Tronco Embrionárias Humanas Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article